相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice
Chaim O. Jacob et al.
ARTHRITIS AND RHEUMATISM (2012)
The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al Reply
Joan T. Merrill
ARTHRITIS AND RHEUMATISM (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses
Claudia Bossen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Cellular Competition Independent of BAFF/B Lymphocyte Stimulator Results in Low Frequency of an Autoreactive Clonotype in Mature Polyclonal B Cell Compartments
Neda Nikbakht et al.
JOURNAL OF IMMUNOLOGY (2011)
B Cell and BAFF Dependence of IFN-α-Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice
Noam Jacob et al.
JOURNAL OF IMMUNOLOGY (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
Xiaohui Zhou et al.
PLOS ONE (2011)
Regulation of the B Cell Receptor Repertoire and Self-Reactivity by BAFF
Miyo Ota et al.
JOURNAL OF IMMUNOLOGY (2010)
Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity
Rei Watanabe et al.
JOURNAL OF IMMUNOLOGY (2010)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
Daniel J. Wallace et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Novel Evidence-Based Systemic Lupus Erythematosus Responder Index
Richard A. Furie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity
William Stohl et al.
JOURNAL OF IMMUNOLOGY (2008)
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus
Maria Dall'Era et al.
ARTHRITIS AND RHEUMATISM (2007)
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF
Chaim O. Jacob et al.
JOURNAL OF IMMUNOLOGY (2006)
Similarities and differences between selective and nonselective BAFF blockade in murine SLE
M Ramanujam et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Expression and occupancy systemic lupus of BAFF-R on B cells in erythematosus
RH Carter et al.
ARTHRITIS AND RHEUMATISM (2005)
BAFF augments certain Th1-associated inflammatory responses
APR Sutherland et al.
JOURNAL OF IMMUNOLOGY (2005)
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
R Lesley et al.
IMMUNITY (2004)
Impaired IgA class switching in APRIL-deficient mice
E Castigli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
APRIL-deficient mice have normal immune system development
E Varfolomeev et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches
M Thien et al.
IMMUNITY (2004)
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
KP Baker et al.
ARTHRITIS AND RHEUMATISM (2003)
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases
V Roschke et al.
JOURNAL OF IMMUNOLOGY (2002)
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
MB Litinskiy et al.
NATURE IMMUNOLOGY (2002)
Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency
MH Yan et al.
CURRENT BIOLOGY (2001)
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF
JS Thompson et al.
SCIENCE (2001)
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
J Zhang et al.
JOURNAL OF IMMUNOLOGY (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth
P Rennert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
BAFF mediates survival of peripheral immature B lymphocytes
M Batten et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
RKG Do et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population
JS Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
SA Marsters et al.
CURRENT BIOLOGY (2000)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice
SD Khare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity
G Yu et al.
NATURE IMMUNOLOGY (2000)
分享论文
